# A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection

> **NCT03658733** · PHASE4 · UNKNOWN · sponsor: **Shandong University** · enrollment: 120 (estimated)

## Conditions studied

- Helicobacter Pylori Infection

## Interventions

- **DRUG:** esomeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days)
- **DRUG:** rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days)

## Key facts

- **NCT ID:** NCT03658733
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-12-15
- **Primary completion:** 2019-08-31
- **Final completion:** 2019-10-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2018-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03658733

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03658733, "A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03658733. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*